AXillary Surgery After NeoAdjuvant Treatment (AXSANA)
A Prospective Multicenter Cohort Study to Evaluate Different Surgical Methods of Axillary Staging (sentinel Lymph Node Biopsy, Targeted Axillary Dissection, Axillary Dissection) in Clinically Node-positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Sponsor: AGO-B
This observational or N/A phase trial investigates Breast Cancer and is currently actively recruiting participants. AGO-B leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
-
Apr 2025 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — Apr 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Jan 2021 — Mar 2024 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Aug 2020 [monthly]
Recruiting
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AGO-B
- AWOgyn
- Claudia von Schilling Foundation for Breast Cancer Research
- Ehmann-Stiftung Savognin
- European Breast Cancer Research Association of Surgical Trialists
- GBG Forschungs GmbH
- North Eastern German Society of Gynaecological Oncology
For direct contact, visit the study record on ClinicalTrials.gov .